Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
Mehmet Aksoy, Erzurum, string:Turkey, Turkey
Memorial Health Services, Long Beach, California, United States
University of Miami, Coral Gables, Florida, United States
The New York and Presbyterian Hospital, New York, New York, United States
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Emory University, Atlanta, Georgia, United States
The Cleveland Clinic Foundation, Cleveland, Ohio, United States
University of Virginia, Charlottesville, Virginia, United States
Linkup Chang Gung Memorial Hospital, Taoyuan City, Taiwan
Nitin Sethi, New Delhi, Delhi, India
Mengchang Yang, Chengdu, Sichuan, China
Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes., Damanhūr, Elbehairah, Egypt
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.